Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission

Completed · Phase 3

Conditions studied: HIV Infections

In brief

The purpose of this study is to see if antibiotic drugs given to treat an infection of the uterus during pregnancy can reduce the chances of HIV being passed from an HIV-positive mother to her baby. A link between bacterial disease of the vagina, premature birth, infection of the uterus during pregnancy, and the passing of HIV from a mother to her baby has been found. Early treatment of these problems may reduce the risk of passing HIV from an HIV-positive mother to her baby. \[Note: As of 02/21/03, enrollment into this study was halted because preliminary data showed that the study antibiotics were not effective in preventing mother-to-child HIV transmission.\]

Key facts

Study ID
NCT00021671
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
3720
Expected to finish
2004-11-01
Last updated by the study team
2021-11-01

Who can join

Age: any. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.